Table 5.
Comparison of clinical characteristics of patients with VZV-positive and CMV-positive secondary glaucoma
| Characteristics | VZV-Positive Patients (N = 13) |
CMV-Positive Patients (N = 25) |
P Valuea |
|---|---|---|---|
| Age (years) | 55.1 (45.0–65.2) | 39.0 (33.4–44.6) | .003* |
| Male gender | 8 (61.5) | 16 (64) | 1.000 |
| Laterality (right) | 9 (69.2) | 12 (48) | .307 |
| IOP (mm Hg) | 32.2 (27.2–37.3) | 29.0 (25.0–33.0) | .015* |
| Cup-to-disc ratio | 0.4 (0.3–0.6) | 0.6 (0.5–0.6) | .093 |
| Corrected visual acuity | |||
| logMAR | 0.8 (0.4–1.3) | 0.3 (0.01–0.6) | .000* |
| Decimal (minutes) | 0.3 (0.1–0.4) | 0.8 (0.6–0.9) | .000* |
| KPs | 13 (100) | 25 (100) | NA |
| Tyndall effect | 10 (76.9) | 3 (12) | .000* |
| Iris depigmentation | 13 (100) | 20 (80) | .144 |
| Cataract | 9 (69.2) | 13 (52) | .490 |
| Medical treatment at the first visit | |||
| Number of patients treated with antiglaucoma medication | 12 (92.3) | 15 (60) | .060 |
| Number of antiglaucoma agents used simultaneously | 2.4 (1.9–2.9) | 1.0 (0.6–1.5) | .001* |
| Frequency of corticosteroid eye drop (times per day) | 3.2 (2.7–3.6) | 2.8 (2.5–3.1) | .110 |
| Surgical intervention | 4 (30.8) | 10 (40) | .728 |
Data are expressed as mean (95% C.I) or number of patients (%)
KPs keratic precipitates, IOP intraocular pressure
aχ2 test or Fisher’s exact test was used to compare proportions between VZV-positive and CMV-positive secondary glaucoma; Mann-Whitney U test was used to compare continuous variables between VZV-positive and CMV-positive secondary glaucoma
*p < .05